Segall Bryant & Hamill’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-12,827
Closed -$1.03M – 618
2025
Q2
$1.03M Sell
12,827
-198
-2% -$15.3K 0.01% 504
2025
Q1
$1.05M Hold
13,025
– – 0.02% 497
2024
Q4
$1.07M Hold
13,025
– – 0.01% 506
2024
Q3
$1.07M Buy
+13,025
New +$973K 0.01% 506
2018
Q3
– Sell
-4,971
Closed -$217K – 862
2018
Q2
$217K Buy
+4,971
New +$232K ﹤0.01% 813
2017
Q4
– Sell
-4,220
Closed -$219K – 580
2017
Q3
$219K Buy
+4,220
New +$206K 0.01% 537

Other funds holding MET

Segall Bryant & Hamill's MET Position: Q3 2025 in Review

Segall Bryant & Hamill sold out of MetLife (MET) in Q3 2025, closing a stake of 12,827 shares — an estimated $1.03M sold.

Segall Bryant & Hamill first reported a position in MET in Q3 2017 and held it in 6 quarters. The position peaked at $1.07M in Q3 2024. 1,369 funds tracked by Wall St. Rank hold MET as of Q3 2025.

  • Segall Bryant & Hamill reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
  • Segall Bryant & Hamill sold 12,827 MetLife shares in Q3 2025, an estimated $1.03M.
  • Segall Bryant & Hamill first reported a position in MetLife in Q3 2017 and held it in 6 quarters.
  • Segall Bryant & Hamill's MetLife position peaked at $1.07M in Q3 2024.
  • 1,369 funds tracked by Wall St. Rank held MetLife as of Q3 2025.

Based on Segall Bryant & Hamill's 13F filing for Q3 2025, filed 12 Nov 2025.